The National Institute of Allergy and Infectious Diseases (NIAID) has updated its HIV Language Guide which aims to help scientists, administrators, and researchers use respectful language and aid funded research networks, sites, centers, investigators, and stakeholders as they develop communications and outreach materials.
Apply to open research positions at the Chicago Center for HIV Elimination, located within the Biological Sciences Division at the University of Chicago.
The Chicago Department of Public Health and Northwestern University want to hear your ideas on how to get new HIV prevention medicine to sexual minority men in Chicago.
Mustanski, professor of medical social sciences at the Feinberg School of Medicine, will focus on social and behavioral sciences.
Public Health Boot Camp is an intensive one-week educational program provided by the AIDS Foundation Chicago and the Institute for Public Health and Medicine at the Northwestern University Feinberg School of Medicine.
The first TC CFAR Directors' Choice publication selected for 2024, “Analysis of the Contribution of 6-mer Seed Toxicity to HIV-1-Induced Cytopathicity,” was recently published in the Journal of Virology.
Jessica Ridgway, MD, MS, at the University of Chicago, is now the director of the CS Core, and Jennifer Jao, MD, MPH, at Northwestern University and Lurie Children’s Hospital, is the co-director for pediatrics and metabolism of the CS Core.
The TC CFAR, which is part of the Institute for Sexual and Gender Minority Health and Wellbeing (ISGMH), is featured in the institute's inaugural annual report.
Four children who acquired HIV in utero have remained free of detectable HIV for more than one year, according to new findings that were presented during the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) in Denver. The study is part of ongoing, multinational research led in part by Drs. Ellen Chadwick and Jennifer Jao.
Third Coast CFAR Developmental Core Co-Director, Elena Martinelli, PhD, and her research team have discovered how blocking an immune cell singling pathway in a model of HIV-1 infection may boost immune responses and decrease viral persistence in combination with antiretroviral therapy.